The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent medical studies. Here are some key dates in the Vioxx saga:
November 17, 2004 Comments Off on Contingency Plans Help Current Merck Crisis Posted in: General Biotechnology Contingency Plans Help Current Merck Crisis : In the wake of Merck & Co.’s announcement to pull Vioxx off the market, the pharmaceutical giant pressed forward with plans to launch new products … The fact that companies such as Merck & Co. can quickly bounce back from troublesome corporate crises is a testament to their […]